We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. In the ADVOR trial, the addition of IV acetazolamide to ...
Adding acetazolamide to conventional loop diuretics can improve the rate of decongestion in hospitalized acute decompensated heart failure (HF) patients better than diuretics alone, according to data ...
Acetazolamide added to intravenous loop diuretics decreases congestion within three days in patients with acute decompensated heart failure, according to late breaking research presented in a Hot Line ...
Introduction: Decongestion is a therapeutic target in acute heart failure (AHF). Acetazolamide is a diuretic that decreases proximal tubular sodium reabsorption, and may also reverse hypochloremia.
Intravenous loop diuretics are recommended for fluid overload in acute decompensated heart failure. A new study examined whether adding acetazolamide could improve decongestion. New research findings ...
Acetazolamide (AZA), a carbonic anhydrase (CA) inhibitor, has been found to alleviate inflammatory and neuropathic pain in rats. In the present study, we investigated the effects of AZA on thermal- ...
IN a recent study of the carbonic anhydrase inhibitors, a low order of toxicity was reported for this group of compounds. 1 Confirmation of this observation is supported by only two previous reports ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results